<!DOCTYPE html><html><head><title>AIDS Drug Assistance Program (ADAP): percentage of identified inappropriate antiretroviral (ARV) regimen components prescriptions that are resolved by the ADAP program during the measurement year.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">AIDS Drug Assistance Program (ADAP): percentage of identified inappropriate antiretroviral (ARV) regimen components prescriptions that are resolved by the ADAP program during the measurement year.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Population Health Quality Measures: Population Structure
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of identified inappropriate antiretroviral (ARV) regimen components prescriptions that are resolved by the AIDS Drug Assistance Program (ADAP) program during the measurement year.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Human immunodeficiency virus (HIV)-related morbidity and mortality has dropped dramatically due to advances in HIV/acquired immune deficiency syndrome (AIDS) treatment. But reductions are uneven across HIV-infected populations due to unequal access to care and variable quality of services provided. Quality management seeks to enhance the quality of HIV care provided and increase access to services. They do so by measuring how health and social services meet established professional standards and user expectations. </p>
<p>The U.S. Public Health Service (PHS) <em>Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents</em> and the <em>Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection</em> specify antiretroviral regimens or components are not generally recommended because of suboptimal antiviral potency, unacceptable toxicities, or pharmacologic concerns (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009; Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2009). AIDS Drug Assistance Program (ADAP) programs are included as core medical services funded by the Ryan White HIV/AIDS Program, and are therefore, required to provide care and treatment consistent with PHS guidelines.</p>
<p><strong>PHS Guidelines</strong></p>
<p class="Center"><strong>Adult and Adolescents Patients: Antiretroviral Regimens or Components That Should Not Be Offered At Any Time</strong> (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009) </p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Adult and Adolescents Patients: Antiretroviral Regimens or Components That Should Not Be Offered At Any Time">
    <thead>
        <tr>
            <th class="Center" valign="top" scope="col">Components not recommended </th>
            <th class="Center" valign="top" scope="col">Exceptions </th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">Atazanavir + indinavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Didanosine + stavudine </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>When no other antiretroviral options are available and potential benefits outweigh the risks </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">2-non-nucleoside reverse-transcriptase inhibitor (NNRTI) combination </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Efavirenz in first trimester of pregnancy or in women with significant child-bearing potential </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>When no other antiretroviral options are available and potential benefits outweigh the risks </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Emtricitabine + lamivudine </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Etravirine + Unboosted protease inhibitor (PI) </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Etravirine + ritonavir-boosted atazanavir or fosamprenavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Etravirine + ritonavir-boosted tipranavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Nevirapine in treament-na&iuml;ve women with CD4 greater than 250 or men with CD4 greater than 400 </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>If no other antiretroviral option available; if used patients should be closely monitored </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Stavudine + zidovudine </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Unboosted darunavir, saquinavir, or tipranavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
    </tbody>
</table>
<p class="Center"><strong>Pediatric Patients: Antiretroviral Components Not Recommended as Part of an Antiretroviral Regimen</strong> (Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2009) </p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Pediatric Patients: Antiretroviral Components Not Recommended as Part of an Antiretroviral Regimen">
    <thead>
        <tr>
            <th class="Center" valign="top" scope="col">Components not recommended </th>
            <th class="Center" valign="top" scope="col">Exceptions </th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">Atazanavir + indinavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Dual nucleoside reverse transcriptase inhibitor (NRTI) combinations:
            <ul style="list-style-type: disc;">
                <li>Lamivudine + Emtricitabine </li>
                <li>Stavudine + Zidovudine </li>
                <li>Stavudine + Didanosine </li>
            </ul>
            </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exception </li>
                <li>No exception </li>
                <li>May be considered for use in antiretroviral-eperienced children who require therapy change </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Efavirenz in first trimester of pregnancy or sexually active adolescent girls of childbearing potential </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>When no other antiretroviral options are available and potential benefits outweigh risks </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Nevirapine initiation in adolescent girls with CD4 greater than 250 cells/mm or adolescent boys with CD4 greater than 400 cells/mm3 </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>Only if benefit clearly outweighs the risk </li>
            </ul>
            </td>
        </tr>
        <tr>
            <td valign="top">Unboosted saquinavir </td>
            <td valign="top">
            <ul style="list-style-type: disc;">
                <li>No exceptions </li>
            </ul>
            </td>
        </tr>
    </tbody>
</table></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Health Resources and Services Administration (HRSA). Deliver HIV/AIDS care: quality of care. [internet]. Rockville (MD): Health Resources and Services Administration (HRSA); [accessed 2016 Jun 23]. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Bethesda (MD): Department of Health and Human Services (DHHS); 2009 Dec 1. 161 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): Department of Health and Human Services (DHHS); 2009 Feb 23. various p. </td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Human immunodeficiency virus (HIV); AIDS Drug Assistance Program (ADAP); antiretroviral regimens</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Number of inappropriate antiretroviral (ARV) regimen components prescriptions included in the U.S. Public Health Service guidelines, <em>Antiretroviral Regimens or Components That Should Not Be Offered At Any Time</em> and <em>Antiretroviral Regimens or Components That Should Not Be Offered for Treatment of Human Immunodeficiency Virus (HIV) Infection in Children</em> that are identified by the AIDS Drug Assistance Program (ADAP) (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Number of antiretroviral (ARV) regimen components prescriptions included in the U.S. Public Health Service guidelines, <em>Antiretroviral Regimens or Components That Should Not Be Offered At Any Time</em> and <em>Antiretroviral Regimens or Components That Should Not Be Offered for Treatment of Human Immunodeficiency Virus (HIV) Infection in Children</em> that are resolved by the AIDS Drug Assistance Program (ADAP) program during the measurement year</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
State/Provincial Public Health Programs
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
State/Provincial
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Does not apply to this measure</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>National Framework for Public Health Quality
</h2>
<div class='field field_picklist-many'>
<h3>
Public Health Aims for Quality
</h3>
<div class='FieldValue'>
Effective
</div>
<div class='FieldValue'>
Population-centered
</div>
<div class='FieldValue'>
Proactive
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Healthy People/Healthy Communities</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Not within an IOM Care Need
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Not within an IOM Domain
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The measurement year</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Clinical information
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Number of inappropriate antiretroviral (ARV) regimen components prescriptions included in the U.S. Public Health Service guidelines, <em>Antiretroviral Regimens or Components That Should Not Be Offered At Any Time</em> and <em>Antiretroviral Regimens or Components That Should Not Be Offered for Treatment of Human Immunodeficiency Virus (HIV) Infection in Children</em> that are identified by the AIDS Drug Assistance Program (ADAP) </p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for additional data elements.</p>
<p><strong>Exclusions</strong><br />
For ADAP clients with multiple sources of funding for their medications, the ADAP program is responsible for identifying only ARV regimen components funded by ADAP.</p></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Number of antiretroviral (ARV) regimen components prescriptions included in the U.S. Public Health Service guidelines, <em>Antiretroviral Regimens or Components That Should Not Be Offered At Any Time</em> and <em>Antiretroviral Regimens or Components That Should Not Be Offered for Treatment of Human Immunodeficiency Virus (HIV) Infection in Children</em> that are resolved by the AIDS Drug Assistance Program (ADAP) program during the measurement year</p>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
National public health data
</div>
<div class='FieldValue'>
State/Province public health data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>ADAP: inappropriate antiretroviral regimen components resolved by ADAP.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
HIV/AIDS Bureau (HAB) Performance Measures
</div>

</div>
<div class='field field_text'>
<h3>
Measure Set Name
</h3>
<div class='FieldValue'>
AIDS Drug Assistance Program
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Health Resources and Services Administration - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Health Resources and Services Administration - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2009 Dec
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="httphttps://hab.hrsa.gov/clinical-quality-management/performance-measure-portfolio" title="Health Resources and Services Administration (HRSA) Web site" target="_blank">Health Resources and Services Administration (HRSA) Web site</a>. </p>
<p>For more information, contact the HRSA HIV/AIDS Bureau (HAB) at 5600 Fishers Lane, Rockville, MD 20857; E-mail: <a href="mailto:HIVmeasures@hrsa.gov">HIVmeasures@hrsa.gov</a>; Web site: <a href="http://www.hrsa.gov/index.html" title="HRSA Web site" target="_blank">www.hrsa.gov/index.html</a>. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on July 8, 2016. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>No copyright restrictions apply.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>